E-Cats University OPAC

Welcome  Guest 

Attrition in the pharmaceutical industry : reasons, implications, and pathways forward / edited by Alexander Alex, C. John Harris, Dennis A. Smith

Material Type Books
Publisher Hoboken, New Jersey : Wiley
Year 2016
Size xiv, 356 p. : illustrations, charts ; 26 cm

Hide book details.

Location Volume Call No. Barcode No. Status ISBN Media type Restriction Request Memo Reserve
第3-1F 閲覧室洋書
499.09/A 41 4000001775 9781118679678 図書

Hide details.

Contents Attrition in drug discovery and development / Scott Boyer, Clive Brealey and Andrew M. Davis
Compound attrition at the pre-clinical phase / Cornelis E.C.A. Hop
Attrition in phase I / Dennis A. Smith and Thomas A. Baillie
Compound attrition in phase II/III / Alexander Alex, C. John Harris, Wilma W. Keighley and Dennis A. Smith
Post-marketing attrition / Dennis A. Smith
Influence of the regulatory environment on attrition / Robert T. Clay
Experimental screening strategies to reduce attrition risk / Marie-Claire Peakman, Matthew Troutman, Rose Gonzales and Anne Schmidt
Medicinal chemistry strategies to prevent compound attrition / J. Richard Morphy
Influence of phenotypic and target-based screening strategies on compound attrition and project choice / Andrew Bell, Wolfgang Fecke and Christine Williams
In silico approaches to address compound attrition / Peter Gedeck, Christian Kramer, Richard Lewis
Current and future strategies for improving drug discovery efficiency / Peter Mbugua Njogu and Kelly Chibale
Impact of investment strategies, organizational structure and corporate environment on attrition, and future investment strategies to reduce attrition / Geoff Lawton
Notes Includes index
Authors *Alex, Alexander A. editor
Harris, C. John editor
Smith, Dennis A. editor
Subjects LCSH:Pharmaceutical industry -- Management
LCSH:Pharmaceutical industry -- Capital productivity
LCSH:Industrial efficiency
LCSH:Drug development
Classification LCC:HD9665.5
DC23:615.1068/5
ID 4000006712
ISBN 9781118679678

Back to Results List Page Top